Home | About Us | Grants | Resources | News & Events | Community

Vision: We may not be there yet, but we are closer than we were yesterday.
Link to Donation Page

detail
Home

About Us
arrowMission
arrowHistory & Background
arrowDisclaimer

Grants
arrowGrant Opportunities
arrowGrant Process
arrowASN Co-Grants
arrowAdvisors
arrow2015 Grant Recipient
arrow
2013 Grant Recipient
arrow
Translational Research

Resources
arrowPatient Registries
arrowPartners
arrowMedical Experts
arrowDefinitions
arrowBio Banks

News & Events
arrow2017 MN Conference in Bergamo
arrow
HFE Gene Linked to MN
arrowCureGN Study at Columbia
arrow
Protein Linked to Kidney Failure
arrowNIH Renews NEPTUNE Funding
arrow
Childhood Stress not trigger for MS
arrowLevin succeeds Remuzzi at ISN

arrowSalant receives Hamburger Award
arrowDrug for MS & Alzheimer's
arrowNeurons & Salt
arrowAutoimmune-Allergy Connection
arrowA Cause of Recurrent MN
arrowBlood Test Detects Kidney Rejection
arrow
Genotyping of Risk Alleles
arrowLink to Gene Variants

arrowBlood Test to Detect MN
arrowMN, an Autoimmune Disease
arrowKey Molecule Impacts Mice
arrowLa Jolla Institute
arrowGluten Specific T-cells
arrowHuman Gene Pool
arrowVitamin D & Clinical Outcomes
arrowBovine Serum Albumen
arrow
Variations in HLA-DQA1 & PLA2R1 regions
arrowKlotho and Kidney Disease
arrowLink between MN and Milk (NEJM)

arrowASN News Release
arrowMario Negri News Release

arrowHyper-IgG4 Syndrome News Release
arrowAdvances in Kidney Disease (RSS)
arrowKidney Disease News (RSS)
arrowNew Patents (RSS)
arrowScience Daily (RSS)
arrowUpcoming Events
arrowEvents Archive

Community
arrowLinks
arrowPublic Service Announcement
arrowOutreach










 

David Salant receives
2013 Jean Hamburger Award

Salant

The Jean Hamburger Award recognizes outstanding research in nephrology with a clinical emphasis. The award was established in memory of Jean Hamburger, the “Professeuer de Paris,” pioneer of clinical nephrology and founding president of the International Society of Nephrology (ISN).

David Salant, M.D. is the recipient of the award from the ISN. Dr. Salant is one of the earliest proponents of the notion that podocyte injury forms the basis of most, if not all, proteinuric kidney diseases. In particular, he was among the first to identify the podocyte as the primary target of injury in antibody-mediated glomerular disease. In a landmark paper in 2009 that was published in the New England Journal of Medicine, he and his colleagues described their discovery that a high proportion of patients with idiopathic membranous nephropathy have circulating autoantibodies to the M-type phospholipase A2 receptor on human podocytes.

Dr. Salant is an advisor on grant selection with the Halpin Foundation. Learn more here: http://halpin.org/grants-advisors.html

Source: The International Society of Nephrology